Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs Payoneer Global Inc (PAYO) Price & Performance

Nuwellis IncTrade
Payoneer Global IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs Payoneer Global Inc — how do they compare? Nuwellis Inc trades at $1.41 (market cap $542.80K), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Payoneer Global Inc is far larger — about 4421.5× Nuwellis Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

NUWEPAYO
Market Cap
$542.80K$2.40B
Sector
TechnologyTechnology
52-Week High
$220.50$7.17
52-Week Low
$1.42$4.27
Enterprise Value
-$1.27M$2.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.

The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.

Payoneer Global Inc

PAYO trades at $7.095, up 0.07% today, near its 52-week high of $7.67. The stock shows a bullish technical signal with moving averages supporting upside, while oscillators are neutral. Recent Q2 2026 earnings missed estimates at $0.02 per share versus $0.06 expected, though revenue grew 10% year-over-year. The pending acquisition by Nuvei for $7.40 per share, announced June 15, 2026, anchors the price near deal terms, with legal inquiries ongoing regarding fairness.

Outlook is acquisition-driven with limited upside to the $7.40 offer, posing a 4.3% gain from current levels. Risks include deal completion uncertainty and earnings volatility, while opportunities lie in potential bid revisions. Analysts maintain a 60% buy rating with an $8.20 consensus target, suggesting confidence in long-term value beyond the takeover.

Returns comparison

Trailing returns across standard periods

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE

About Payoneer Global Inc

Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.

Read more on PAYO